Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Guardian Pharmacy (GRDN) Surges 8.8%: Is This an Indication of Further Gains?

Guardian Pharmacy Services, Inc. Announces Leadership Transitions

Guardian Pharmacy Services, Inc. (GRDN) Hit a 52 Week High, Can the Run Continue?

Guardian Pharmacy Services, Inc. (GRDN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Guardian Pharmacy Services Q1 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) Q1 Earnings and Revenues Surpass Estimates

Guardian Pharmacy Services, Inc. (GRDN) Q1 2026 Earnings Call Transcript

Guardian Pharmacy Services Reports First Quarter 2026 Financial Results; Updates Full-Year Guidance

Stevanato Group (STVN) Reports Next Week: Wall Street Expects Earnings Growth

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Buy” by Analysts

Guardian Pharmacy Services, Inc. to Participate in the Bank of America 2026 Healthcare Conference

Guardian Pharmacy Services, Inc. to Report First Quarter 2026 Financial Results and Host Conference Call

Best Momentum Stocks to Buy for April 10th

New Strong Buy Stocks for April 10th

Earnings Estimates Moving Higher for Guardian Pharmacy (GRDN): Time to Buy?

Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?

Best Momentum Stocks to Buy for March 30th

New Strong Buy Stocks for March 30th

Market Today: Oil Rebounds; Disney Exits OpenAI Deal; Gilead Buys Ouro

Bet on Winning DuPont Analysis & Pick 5 Top Stocks

Guardian Pharmacy Services Announces Pricing of Upsized Underwritten Public Offering of Class A Common Stock

Guardian Pharmacy Services Announces Launch of Underwritten Public Offering of Class A Common Stock

Guardian Pharmacy Services, Inc. (GRDN) Q4 2025 Earnings Call Transcript

Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates

Guardian Pharmacy Services Reports Fourth Quarter and Full Year 2025 Financial Results; Raises 2026 Adjusted EBITDA Guidance

Guardian Pharmacy Services, Inc. to Participate in Upcoming Oppenheimer Healthcare MedTech & Services Conference

All You Need to Know About Guardian Pharmacy (GRDN) Rating Upgrade to Buy

Guardian Pharmacy Services, Inc. to Participate in Upcoming Raymond James Institutional Investor Conference

Guardian Pharmacy Services, Inc., to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Conference Call

Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Rating of “Moderate Buy” by Brokerages

Short Interest in Guardian Pharmacy Services, Inc. (NYSE:GRDN) Rises By 33.3%

Rakuten Investment Management Inc. Takes Position in Guardian Pharmacy Services, Inc. $GRDN

Guardian Pharmacy Services, Inc. (GRDN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Guardian Pharmacy Services Reiterates 2025 Guidance and Provides 2026 Outlook

Guardian Pharmacy Services, Inc. to Participate in Upcoming J.P. Morgan Healthcare Conference

Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast

Why Guardian Pharmacy Services Stock Was on a Tear Tuesday

Guardian Pharmacy Services (GRDN) Q3 Earnings and Revenues Surpass Estimates

Guardian Pharmacy Services, Inc. (GRDN) Q3 2025 Earnings Call Transcript

Guardian Pharmacy Services Reports Third Quarter 2025 Financial Results; Raises Full-Year Guidance

Guardian Pharmacy Services (GRDN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference

Guardian Pharmacy Services Announces Filing of S-3 Shelf Registration Statement and Lock-up Agreements with Pre-IPO Holders of Class A Common Stock

Guardian Pharmacy Services, Inc. to Report Third Quarter 2025 Financial Results and Host Conference Call

Guardian Pharmacy Services, Inc. (GRDN) Presents at Jefferies 2025 Healthcare Services Conference Transcript

Guardian Pharmacy Services, Inc. to Participate in Upcoming Jefferies Healthcare Services Investor Conference

Guardian Pharmacy Services (GRDN)'s Technical Outlook is Bright After Key Golden Cross

Guardian Pharmacy (GRDN) Upgraded to Buy: What Does It Mean for the Stock?